Senate OKs Drug Exclusivity Change To Boost Generics
The Senate has easily approved two bipartisan bills meant to lower prescription drug prices by boosting generics and biosimilars, including one proposal to tighten eligibility for the new drug exclusivity period...To view the full article, register now.
Already a subscriber? Click here to view full article